First Time Loading...
C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.75 AUD Market Closed
Updated: Apr 29, 2024

Cyclopharm Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cyclopharm Ltd
Operating Income Peer Comparison

Comparables:
NTI
IPD
COH
OIL
EMV

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Cyclopharm Ltd
ASX:CYC
Operating Income
-AU$8.6m
CAGR 3-Years
-16%
CAGR 5-Years
-119%
CAGR 10-Years
-25%
Neurotech International Ltd
ASX:NTI
Operating Income
-AU$7.8m
CAGR 3-Years
-82%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
ImpediMed Ltd
ASX:IPD
Operating Income
-AU$20.7m
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-12%
Cochlear Ltd
ASX:COH
Operating Income
AU$491.1m
CAGR 3-Years
36%
CAGR 5-Years
6%
CAGR 10-Years
15%
Optiscan Imaging Ltd
ASX:OIL
Operating Income
-AU$5.7m
CAGR 3-Years
-66%
CAGR 5-Years
-21%
CAGR 10-Years
-11%
EMvision Medical Devices Ltd
ASX:EMV
Operating Income
-AU$3.8m
CAGR 3-Years
2%
CAGR 5-Years
-35%
CAGR 10-Years
N/A

See Also

What is Cyclopharm Ltd's Operating Income?
Operating Income
-8.6m AUD

Based on the financial report for Dec 31, 2023, Cyclopharm Ltd's Operating Income amounts to -8.6m AUD.

What is Cyclopharm Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-25%

Over the last year, the Operating Income growth was -46%. The average annual Operating Income growth rates for Cyclopharm Ltd have been -16% over the past three years , -119% over the past five years , and -25% over the past ten years .